1-3 of 3
Tooru Kudoh
Close
Sort by
Journal Articles

Continuous Cytarabine Plus Dexamethasone in Consolidation Phase to Patients with Childhood ALL: Result from Japan Association of Childhood Leukemia Study - JACLS ALL02 Protocol -

So-ichi Suenobu, MD PhD, Ikuya Usami, MD PhD, Toshihiko Imamura, MD PhD, Hirohide Kawasaki, MD PhD, Keiko Yumura Yagi, MD PhD, Shinichiro Nishimura, MD PhD, Makoto Kaneda, MD PhD, Yoshihiro Takahashi, MD PhD, Daiichiro Hasegawa, MD PhD, Nobuhiro Suzuki, MD PhD, Yoshiko Hashii, MD PhD, Takao Deguchi, MD PhD, Saito Akiko, MD PhD, Koji Kato, MD PhD, Yoshiyuki Kosaka, MD PhD, Mikiya Endo, MD PhD, Akihiro Iguchi, MD PhD, Megumi Oda, MD PhD, Hiroki Hori, MD PhD, Atsushi Sato, MD PhD, Tatsutoshi Nakahata, MD PhD, Tooru Kudoh, MD PhD, Junichi Hara, MD PhD, Keizo Horibe, MD PhD
Journal: Blood
Blood (2016) 128 (22): 2802.
https://doi.org/10.1182/blood.V128.22.2802.2802
Published: 2016
Journal Articles

Improved Outcome of Childhood Acute Lymphoblastic Leukemia (ALL) with Induction Failure Treated on the Japan Association of Childhood Leukemia Study (JACLS) ALL F-Protocol.

Nobuhiro Suzuki, Keiko Yumura-Yagi, Junichi Hara, Makoto Yoshida, Shinichiro Nishimura, Tooru Kudoh, Akio Tawa, Ikuya Usami, Akihiko Tanizawa, Hiroki Hori, Yasuhiro Ito, Ryosuke Miyaji, Yoshihiro Komada, Megumi Oda, Keizo Horibe
Journal: Blood
Blood (2006) 108 (11): 1886.
https://doi.org/10.1182/blood.V108.11.1886.1886
Published: 2006
Journal Articles

Effective Risk-Adapted Therapy for Childhood B-Precursor Acute Lymphoblastic Leukemia (ALL) with the Japan Association of Childhood Leukemia Study (JACLS) ALL-97 Protocol.

Keizo Horibe, MD, Tooru Kudoh, MD, Hiroki Hori, MD, Shinichiro Nishimura, MD, Megumi Oda, MD, Makoto Yoshida, MD, Yoshihiro Komada, MD, Junichi Hara, MD, Akio Tawa, MD, Ikuya Usami, MD, Akihiko Tanizawa, MD, Keiko Yumura-Yagi, MD
Journal: Blood
Blood (2006) 108 (11): 1874.
https://doi.org/10.1182/blood.V108.11.1874.1874
Published: 2006